What Happened?

Shares of health insurance company Clover Health (NASDAQ: CLOV) jumped 2.5% in the afternoon session after Canaccord Genuity maintained its 'Buy' rating and $3.70 price target on the company. 

The rating was reiterated by analyst Richard Close. This action indicated continued confidence in the company's valuation and future outlook. The positive view was supported by Clover Health's technology-first care model, which had resulted in solid membership growth, rising revenues, and sustained adjusted EBITDA profitability, reinforcing the basis for the optimistic rating.

After the initial pop the shares cooled down to $2.61, up 2.6% from previous close.

Is now the time to buy Clover Health? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Clover Health’s shares are extremely volatile and have had 37 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 6 days ago when the stock gained 10% on the news that the company announced a 53% year-over-year increase in its Medicare Advantage membership and stated that it expected its first-ever full year of net income profitability in 2026. 

Following a strong Annual Enrollment Period, Clover's membership grew to approximately 153,000. The company attributed the positive outlook to this disciplined growth, strong member retention of over 95%, and improved operational efficiencies. Management also highlighted that better cohort economics and enhanced Star Ratings supported the company's path toward profitability and potential margin expansion.

Clover Health is up 8.1% since the beginning of the year, but at $2.61 per share, it is still trading 46% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health’s shares 5 years ago would now be looking at an investment worth $189.73.

The 1999 book Gorilla Game predicted Microsoft and Apple would dominate tech before it happened. Its thesis? Identify the platform winners early. Today, enterprise software companies embedding generative AI are becoming the new gorillas. Click here for access to our special report that reveals one profitable leader already riding this wave, it’s free.